Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-04-23 @ 3:50 AM
Study NCT ID:
NCT06136351
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor:
Organization: